IMAC Holdings (BACK) Explodes 94% Higher Post Reverse Split, With 42 Million Shares Trading...

Simply Incredible! 2024 Will be the Year of Post Reverse Split Revenge! Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. IMAC owns and...

China Remains at Risk to Future MonkeyPox Outbreaks.

GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox. The World Health Organization just updated global...

GeoVax Live Webcast

Tonight, Monday at 5:30 PM. And You Don't Fly to Newport Beach and Deal With all the Drinking, Investment Bankers, and Hedge Fund Managers,...

Killer, 44-Page Report on GeoVax (GOVX).

And a Nine-Page Summary Report..Great Weekend Reading. This is one killer report. In fact if we might be so bold, we might even call it...

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

New report nearly doubles the GeoVax addressable market of Immunocompromised Patients (i.e. potential customers) from 15 Million, to 23 Million patients! Not updated were...

Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX) Vaccine for Leukemia...

Dr. Don Diamond has stated, "The City of Hope is excited to license this vaccine to GeoVax (GOVX) to progress to large-scale clinical trials...

Geovax (GOVX) – City of Hope Covid Vaccine for Chronic Lymphocytic Leukemia Patients. Interview...

Explosive Interview About GeoVax's Covid vaccine with the brilliant Dr. Don J. Diamond, Ph.D., professor at City of Hope and GeoVax vaccine’s lead developer....

The Extraordinary Dr. Koffman, Who Beat Leukemia.

Dr. Brian Koffman is extraordinary, in many ways. He’s extraordinary in the medical sense because, after twelve years of battling blood cancer, doctors can...

GeoVax (GOVX) Conference Call at 4:30 ET, the 29th.

GeoVax to Host Conference Call at 4:30 PM ET GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 ATLANTA, GA, Feb....

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants We were having cocktails at a fancy restaurant last night with a hedge fund manager, who manages...

Latest article

Y-Combinator | Top 10 Performing Portfolio Holdings

Y Combinator, LLC (YC) is an US based technology startup accelerator and venture capital firm launched in March 2005, has incredibly been used to...

Society Pass (SOPA) Perking Up, Gains 169% in Last Trading Five Days.

For the record, we are not traders. And that 'not-something-moniker' dates back to 1995. So while it's nice to see it perking up, we...

Sekur Private Data (SKUR, SWISF) Inching Towards a Double!

Sekur Private Data has been slowly working it's way higher, on a series of positive news events. Here are the headlines and short to...